MHRA extends the license of two cystic fibrosis drugs for children aged two to five years old

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (15 November 2023) extended the licence of the cystic fibrosis medicines Kaftrio (ivacaftor, tezacaftor and elexacaftor) and Kalydeco (ivacaftor) for children aged two to five years old.

Improving gut health may be key to slowing HIV progression to AIDS

Restoring and improving gut health may be key to slowing HIV progression to AIDS, according to a new study by University of Pittsburgh infectious diseases

July 24, 2023

Year End results as of December 31, 2023 – Biotech Investments

Vitruvia Medical AG / Key word(s): Annual Results/Annual Report Vitruvia Medical AG: Year End results as of December 31, 2023 01-May-2024 / 08:36 CET/CEST Disclosure

May 2, 2024

Trans People on Hormone Therapy Don’t Mind Potential Cardiovascular Side Effects

Trans adults using gender-affirming hormone therapy said they were content that it helped their overall well-being and, indirectly, felt it benefited their cardiovascular health, researchers

July 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.